TP53 and non-small cell lung carcinoma: Studies have revealed that silencing of SNRPD3 causes overexpression of p53 levels, thereby modulating CDKN1A expression and further influencing the cell cycle arrest and cell death of NSCLC cells (Siebring-van Olst et al., 2017).